title: [Effect of berberine bisulfate on platelet hemostasis in thrombocytopenia patients].
abstract: The authors recommend berberine bisulfate for use as thrombocytopoiesis stimulator in thrombocytopenias as they have found secondary therapeutic property of this drug--to increase platelet count in patients with primary and secondary thrombocytopenia. The drug was given as monotherapy and in combined treatment 3 times a day for 15 days in a dose 5 mg 20 min before meals.
authors.forename: S I
authors.initials: SI
authors.lastname: Chekalina
authors.forename: R Z
authors.initials: RZ
authors.lastname: Umurzakova
authors.forename: K K
authors.initials: KK
authors.lastname: Saliev
authors.forename: T R
authors.initials: TR
authors.lastname: Abdurakhmanov
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001599:Berberine / Q000031:analogs & derivatives / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects*; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D010976:Platelet Count / Q000187:drug effects; D013921:Thrombocytopenia / Q000097:blood / Q000188:drug therapy*
chemical_list: D001599:Berberine
vernacular_title: Vliianie berberina bisul'fata na trombotsitarnyĭ gemostaz u bol'nykh s trombotsitopeniiami.